Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Strides Arcolab
Strides Arcolab
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Indian Stride Pharma acquires FDA-approved US manufacturing facility
The facility will meet the enhanced capacity needs for soft gels and will offer an alternate site to Strides’ flagship facility in Bangalore
Finance
Strides Shasun acquires three OTC brands from Moberg Pharma
Indian firm is building an over-the-counter drug franchise in regulated and emerging markets
Finance
Sun Pharma to sell Ranbaxy's CNS divisions to Strides Arcolab
Deal is of strategic significance to growth of Strides branded business in India
Finance
Strides to buy drug assets in Australia and Mauritius from Aspen for approximately US$300m
Part of aim to focus on areas where most value can be added, says Strides
Manufacturing
Stelis Biopharma begins construction of US$60m multiproduct biologics facility in Malaysia
Will incorporate the latest single-use bioreactor systems for scale-up and process development
Vietnam bans companies making \'substandard\' drugs
Companies banned include 45 Indian pharmaceutical companies along with others from Korea, France and Pakistan
Finance
US regulators put conditions of Mylan Agila deal
Companies will have to divest 11 generic injectable drugs as a condition of approving the deal
Subscribe now